Autolus Therapeutics plc American Depositary Share (NASDAQ: AUTL) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT AUTOLUS THERAPEUTICS PLC AMERICAN DEPOSITARY SHARE

Autolus Therapeutics plc American Depositary Share (NASDAQ: AUTL)
Listen to this Section


$1.47
+0.0650 ( +4.64% ) 641.8K

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Market Data


Open $1.47
Previous Close $1.40
Volume 641.8K
Market Cap $372.60M
Day Range $1.38 - $1.49
52 Week Range $1.18 - $2.70
Shares Outstanding 266.14M
Change % +4.64%
Net Change ▲ 0.0650
Insider Ownership N/A
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2018
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 44 Nov 12, 2025
10-q Quarterly Reports 96 Nov 12, 2025
8-k 8K-related 35 Aug 12, 2025
10-q Quarterly Reports 132 Aug 12, 2025

Latest News